ScienceExperimental drug cuts COPD flare-ups by 38% in Southampton-led trial
Monthly injection of tavrelimab, an antibody targeting airway inflammation, reduced hospital admissions in 1,800 patients across 42 NHS sites over a year
6 min read
LB
Laura Bexley
Health correspondent
Laura writes for the Daily Meridian. 1 article.